Lacosamide Tablet, Film Coated
Product Images NDC 51407-721

This is a medication called Lacosamide, USP with a strength of 50mg in each tablet. It comes in a bottle of 60 tablets and is only available with a prescription. There is a recommended dosage provided in the Prescribing Information. It is important to keep this medication out of the reach of children and to store it at a controlled room temperature of 20-25°C (68-77°F) with permitted excursions between 15-30°C (59-86°F). The medication guide for this product can be found at https://gsms.us/. It is manufactured by MSN Laboratories Private Limited and marketed by GSMS, Incorporated in Camarillo, California.*

NDC 51407-722-60 is a medication containing 100 mg of lacosamide, USP. It comes in the form of tablets, and the recommended dosage can be found in the accompanying Prescribing Information. This medication is meant to be kept out of reach of children and stored at a temperature between 20° - 25°C (68° - 77°F), with slight excursions permitted between 15° - 30°C (59° - 86°F). The medication should be dispensed by a pharmacist alongside a Medication Guide, which can be found printed online. The medication is manufactured by MSN Laboratories Private Limited and marketed by GSMS, Incorporated. Only available with a prescription.*

This is a description of a medication with the National Drug Code 51407-723-60. Each tablet contains 150 mg of lacosamide, USP. This drug is available in the form of tablets, USP. The dosage is specified in the accompanying Prescribing Information. It should be kept away from children and stored at a controlled room temperature between 20° - 25°C (68° - 77°F); with excursions permitted between 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature]. The medication guide should be printed and dispensed with each patient by the pharmacist. It is manufactured by MSN Laboratories Private Limited and marketed by GSMS, Incorporated. This medication requires a prescription.*

This is information about a medication called Lacosamide in tablet form containing 200 mg of the drug. The dosage instructions are not provided and can be found in the accompanying Prescribing Information. The medication should be kept away from children and stored between 68° - 77°F with some flexibility in temperature. The manufacturer is listed as MSN Laboratories Private Limited and the medication is marketed by GSMS, Incorporated. A Medication Guide should be given to each patient by the pharmacist.*

The image shows a figure depicting the median percent reduction in seizure frequency from baseline to the maintenance phase by dose. The figure includes data from three studies and compares the effects of placebo and Lacosamide Tablets. The text notes that there is a statistically significant difference between the effects of Lacosamide Tablets and placebo.*

This is a chart showing the responder rate, improvement, and worsening percentages for different dosages of Lacosamide and a placebo. There are no further details provided.*